Phenomenex Sues Thermo Fisher over Claims About LC Columns | GenomeWeb

In a lawsuit filed this week, separation science firm Phenomenex accused Thermo Fisher Scientific of false advertising in an e-mail that compared each company's liquid chromatography columns.

The suit was filed in US District Court, Central District of California.

In its complaint, Phenomenex, based in Torrance, Calif. alleges that a Thermo Fisher manager for LC and LC-MS columns sent an e-mail on or about Oct. 17 to that firm's distributors. The e-mail contained false and misleading claims about Phenomenex's Kinetex LC columns, Phenomenex alleges.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In PNAS this week: adzuki bean genome, spontaneous mutation patterns in E. coli, and more.

An op-ed in the New York Times discusses banking of fecal samples to restore the gut microbiome.

Rules and regulations governing genetic modifications of human embryos vary from country to country, Nature News says, but such work may take place despite restrictions. is eyeing an expansion into genomic risk assessments, the Verge reports.